FRANKLIN LAKES, NJ – BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the Conformité Européenne (CE) Marked BD Onclarity™ HPV Assay for the BD COR™… Read More
– EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is now the first and only bispecific antibody combination therapy available for patients with relapsed or refractory follicular lymphoma after at least one… Read More
First-line treatment with TREMFYA® shows significant inhibition of radiographic progression at Week 24, which was sustained through Week 48, preserving joint health with a well-established safety profile More than half of… Read More
Ziihera® plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab and chemotherapy, and a clinically meaningful effect with a strong trend toward statistical significance for… Read More
Researchers from UBC and Vancouver Coastal Health are developing natural plant compounds into a healing gel that could speed up recovery and prevent wounds from returning. Vancouver, BC — Every day… Read More
